Advertisement

Diabetes Companies in BioPortfolio's Corporate DatabaseTwitter RSS

09:51 EDT 23rd May 2013 | BioPortfolio

Diabetes company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Diabetes companies that have been added to our BioPortfolio's life-science corporate directory.

Search For More Diabetes Companies

If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Diabetes Companies.

More Information about Diabetes on BioPortfolio

We have published hundreds of Diabetes news stories on BioPortfolio along with dozens of Diabetes Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Diabetes for you to read.

Showing "diabetes diabetic mellitus" Companies 1 to 25 of 479

Tuesday 21st May 2013

American Association of Clinical Endocrinologists

AACE is a professional medical organization with more than 6,000 members in the United States and 91 other countries. AACE members are physicians who specialize in endocrinology, diabetes, and metabolism. For more information about AACE, visit our Web site at www.aace.com, become a fan on Facebook at www.facebook.com/theaace or follow us on Twitter at www.twitter.com/theaace.

Thursday 16th May 2013

Diabetes Care Club

Diabetes Care Club, a Simplex brand, has grown to become the third largest mail-order supplier of diabetic testing supplies for seniors. The company provides home delivery of medical supplies for patients with diabetes and a social network that offers help, support and information for people living with the disease. For additional information, visit www.Di...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and gr...

Defymed

Defymed is a spin -off of the “Centre Europeen d’etude du Diabete”  (CeeD) which has been working on the conception of a bio-artificial pancreas since 1996. This work was carried out in tight collaboration with the “Centre de Transfert de Technologie du Mans” (CTTM) and STATICE in the frame of two research European programs: FP4 (1996-2000) and FP6 (2004-2007...

Tuesday 14th May 2013

Devon Medical, Inc.

Devon Medical, Inc. (www.devonmedicalproducts.com) is an ISO 13485 certified medical device manufacturer, designer, and distributor. Since 2005, we have developed innovative and high-quality medical devices that are affordable for healthcare markets and patients worldwide. Our exclusive therapeutic devices treat and prevent various types of wounds and heal...

Eli Lilly and Company

Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions. We are committed to provi...

Thursday 9th May 2013

Plandaí­ Biotechnology, Inc.

Plandaí­ Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. Our headquarters are in Seattle, Washington, USA. Although we also have a global presence with offices in London, England and Nelspruit in the province of Mpumalanga, South Africa...

Izun Pharmaceuticals Corporation

Izun Pharmaceuticals is a US based pharmaceutical company with a wholly owned R&D center in Israel. Izun’s technology platform allows it to develop botanical drugs by optimizing and purifying the extracted botanical compounds to yield polymolecular drug candidates. These patented products are designed to impact on multiple specific receptor targets. T...

Wednesday 8th May 2013

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide. The company’s orally-delivered VCM therapies, which selectively target cells within the retina to protect visual acui...

Tuesday 7th May 2013

Islet Sciences, Inc.

Islet Sciences is a development-stage biotechnology company with patented technologies focused on infusion therapy for people with insulin-dependent diabetes. The Company's infusion technology includes methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. The Company's mission includes the introduction...

Opsona Therapeutics Ltd.

Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, solid organ transplantation, cancer, diabetes, Alzheimer's disease and others. The company was founded in 2004 by...

Monday 6th May 2013

TheAmerican Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Endocrinology, Diabetes and Metabolism and concentrate on the treatment of patients with endocrine...

Saturday 4th May 2013

Roche Applied Science

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based...

GlycoMark Inc.

GlycoMark Inc. is a joint venture by Toyota Tsusho America Inc. (New York, N.Y.), Nippon Kayaku (Tokyo, Japan), and the BioMarker Group (N.C.). Located in New York, N.Y., and Winston-Salem, N.C., GlycoMark Inc. is dedicated to the discovery and commercialization of novel biomarkers for diabetes.

Dance Pharma

Dance is a San Francisco based, global company focused exclusively on creating a line of small, patient friendly, pain-less, low cost insulin inhalers for the world diabetes market. In addition to providing inhaled insulin to those who have become insulin dependent, the company also intends to enable introduction of insulin much earlier in the disease proc...

PamLab L.L.C.

Pamlab, L.L.C., founded in 1957, is a fully integrated pharmaceutical company specializing in medical foods indicated for specific disease states including diabetic neuropathy, depression and early memory loss.

Pamlab, L.L.C.

Pamlab, L.L.C., founded in 1957, is a fully integrated pharmaceutical company specializing in medical foods indicated for the nutritional support of specific disease states including diabetic neuropathy, depression and early memory loss.

America Stem Cell, Inc.

America Stem Cell is a privately held biotechnology company based in San Antonio, TX, with offices in San Diego, CA, and is dedicated to the development and commercialization of stem cell enabling technologies/products to transform clinical outcomes for patients undergoing stem cell transplantation. The key stem cell enabling platform technologies/compound...

IDEAL LIFE Inc.

IDEAL LIFE, the industry leader in remote health management solutions, has created an innovative platform that addresses many of today’s most challenging and costly healthcare issues. Guided by a medical advisory panel of experts, the IDEAL LIFE program makes proactive prevention more realistic than ever as it is instrumental in gauging health issues...

Team Type 1

Based in Atlanta, GA, Team Type 1 began as a grassroots initiative to motivate people to take control of their diabetes using cycling as a platform. It grew to become a world-class athletic program for all athletes with diabetes, including a professional men's cycling team, poised to compete at the 2012 Tour de France. Today, it is a global sports organiza...

ApoCell, Inc.

Based in Houston, Texas, ApoCell (www.apocell.com) is a privately-held specialty clinical research company. Founded in 2004, the firm is a leader in molecular biomarker detection and analysis and leverages its expertise in the areas of oncology, diabetes, molecular diagnostics and drug development to measure biomarker signatures in clinical trial subjects....

LW Robbins

LW Robbins (www.lwra.com) is a full service direct response fundraising agency devoted to helping nonprofit organizations acquire and cultivate loyal donors, and raise more net income to support their missions. The agency’s clients, including Special Olympics, Juvenile Diabetes Research Foundation, St. Labre Indian School, The UN Refugee Agency, MAP I...

PamLab, LLC

Pamlab, L.L.C., founded in 1957, is a fully integrated pharmaceutical company specializing in medical foods indicated for the nutritional support of specific disease states including diabetic neuropathy, depression and mild cognitive impairment.

Lotus Tissue Repair, Inc.

Lotus Tissue Repair, Inc. is developing its proprietary recombinant collagen type VII (rC7) technology as a treatment for dermatologic conditions in which rC7 may play an important role in accelerating chronic wound healing, such as diabetic foot ulcers, venous stasis ulcers and similar conditions. The company’s lead program is the first and only prot...

Akebia Therapeutics, Inc.

Akebia Therapeutics is a discovery and development company focused on anemia and vascular disorders. Akebia’s lead program, AKB-6548, an orally bioavailable HIF-prolyl hydroxylase (HIF-PH) inhibitor for patients with anemia, is in phase 2 clinical trials. AKB-6548 potentially promises to be a safer, less expensive, orally dosed pharmaceutical to stimu...


More From BioPortfolio on "Diabetes Companies in BioPortfolio's Corporate Database"

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks

Advertisement